Growth response to antiretroviral treatment in HIV‐infected children: a cohort study from Lilongwe, Malawi
暂无分享,去创建一个
M. Egger | O. Keiser | H. Tweya | S. Phiri | M. Brinkhof | R. Weigel | Fred Chiputula | T. Gsponer | J. Gumulira
[1] S. Filteau. The HIV‐exposed, uninfected African child , 2009, Tropical medicine & international health : TM & IH.
[2] A Sarah Walker,et al. Differences in Factors Associated With Initial Growth, CD4, and Viral Load Responses to ART in HIV-Infected Children in Kampala, Uganda, and the United Kingdom/Ireland , 2008, Journal of acquired immune deficiency syndromes.
[3] A. Bandyopadhyay,et al. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy , 2008, Annals of tropical paediatrics.
[4] A. Tomkins,et al. Nutritional recovery in HIV-infected and HIV-uninfected children with severe acute malnutrition , 2008, Archives of Disease in Childhood.
[5] W. Moss,et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. , 2008, The Lancet. Infectious diseases.
[6] A. Tomkins,et al. The impact of HIV on mortality during in-patient rehabilitation of severely malnourished children in Malawi. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] F. Dabis,et al. Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration. , 2008, International journal of epidemiology.
[8] K. Maleta,et al. HIV prevalence in severely malnourished children admitted to nutrition rehabilitation units in Malawi: Geographical & seasonal variations a cross-sectional study , 2008, BMC pediatrics.
[9] M. Chhagan,et al. Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence , 2008, The Lancet.
[10] W. Chan,et al. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. , 2008, AIDS patient care and STDs.
[11] H. Zar,et al. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis , 2008, AIDS.
[12] A. Muula,et al. Human resources requirements for highly active antiretroviral therapy scale-up in Malawi , 2007, BMC Health Services Research.
[13] E. Molyneux,et al. Experience of anti-retroviral treatment for HIV-infected children in Malawi: the 1st 12 months , 2007, Annals of tropical paediatrics.
[14] B. Chi,et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. , 2007, JAMA.
[15] K. Mandaliya,et al. Efficacy of Highly Active Antiretroviral Therapy in HIV-1–Infected Children in Kenya , 2007, Pediatrics.
[16] H. Chiang,et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi , 2007, AIDS.
[17] J. Overbaugh,et al. Early Response to Highly Active Antiretroviral Therapy in HIV-1-Infected Kenyan Children , 2007, Journal of acquired immune deficiency syndromes.
[18] C. Kankasa,et al. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] J. Bellón,et al. Impact on Weight and Height With the Use of HAART in HIV-Infected Children , 2007, The Pediatric infectious disease journal.
[20] C. Yiannoutsos,et al. Outcomes of HIV-Infected Orphaned and Non-Orphaned Children on Antiretroviral Therapy in Western Kenya , 2006, Journal of acquired immune deficiency syndromes.
[21] T. Taylor,et al. Observational Cohort Study of HIV-Infected African Children , 2006, The Pediatric infectious disease journal.
[22] J. Lindsey,et al. Growth of Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy , 2005, The Pediatric infectious disease journal.
[23] S. Hirschfeld,et al. Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials. , 2004, The Journal of antimicrobial chemotherapy.
[24] S. Blanche,et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire , 2004, AIDS.
[25] D. Weber,et al. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV , 2003, AIDS.
[26] R. de Groot,et al. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. , 2002, Pediatrics.
[27] L. Molinari,et al. Growth in human immunodeficiency virus type 1- infected children treated with protease inhibitors , 2001, European Journal of Pediatrics.
[28] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[29] G. Malenga,et al. The impact of the human immunodeficiency virus type 1 on the management of severe malnutrition in Malawi , 2000, Annals of tropical paediatrics.
[30] P. Royston,et al. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .
[31] R. Reed,et al. NCHS growth curves for children birth-18 years. United States. , 1977, Vital and health statistics. Series 11, Data from the National Health Survey.
[32] Emiko Masaki,et al. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. , 2007 .
[33] S. Knobler,et al. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach , 2005 .
[34] D. Weber,et al. Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings. , 2004, AIDS patient care and STDs.